Jena, Germany, February 19, 2020 - InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, will present at the 9th Annual SVB Leerink Global Healthcare Conference February 25-27, 2020 at the Lotte New York Palace in New York, NY, USA. An SVB Leerink analyst will moderate a discussion with Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, about the Company`s pipeline and important upcoming catalysts on Wednesday, February 26th at 9:00 am EST (3:00 pm CET). A live webcast of the presentation will be provided on the InflaRx website in...
|
